Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Pfizer

Covid vaccine to be offered to vulnerable babies and children in UK

Eligible children between six months and four years old will be offered jab from June

The Guardian - UK

Ursula von der Leyen: EU’s ‘general’ nears endgame of turbulent first term

European Commission president is praised for work ethic and response to Covid and Ukraine war, but some see her as aloof

The Guardian - UK

Institute offers booster shots

The Institute of Dermatology is offering a Covid-19 vaccination service using the Gen2-Bivalent Pfizer vaccine at its headquarters on Ratchawithi Road.

Bangkok Post

From analysis to the latest developments in health,
read the most diverse news in one place.

Covid booster jab rollout to begin for 5 million most vulnerable people

Cases are at their highest level since the start of the year, according to last ever ONS survey

The Independent UK

Covid booster vaccine to be offered to millions in England next week

Care home residents will be first to receive spring top-up jab as infections in England hit 2023 high

The Guardian - UK

Spring Covid booster campaign set to launch next week

Around five million UK residents are eligible for the booster until the end of June

Wales Online

Spring Covid booster campaign gets under way next week

Millions of people will be sent their initial invitations through the NHS app, where they can also book their appointment.

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

J&J Drops Out Of A Key Race, Leaving Pfizer, GSK, Moderna To Duke It Out

Johnson & Johnson ducked out of the RSV vaccine race Wednesday, leaving Pfizer, GSK and Moderna to duke it out.

Investors Business Daily

TGA weighs up RSV vaccine for older Australians

A vaccine for the potentially deadly respiratory syncytial virus (RSV) is being assessed by the TGA for use by people aged over 60.

The New Daily

I Finally Caught COVID. The Government Made the Experience Even Worse.

Thanks to onerous regulations, life-saving drugs are more expensive and harder to get.

Reason

Pfizer's chief corporate affairs officer remembers the moment she figured out how to 'break through' to skeptical consumers during COVID

Sally Susman is the author of "Breaking Through: Communicating to Open Minds, Move Hearts, and Change the World."

Fortune

BioNTech Stock Crumbles After 2023 Outlook Misses By Almost $3 Billion

BioNTech said Monday it expects roughly $5.4 billion in sales of its Covid shot this year, missing views and leading BNTX stock to tumble.

Investors Business Daily

Chinese Foreign Minister Qin Gang assures US business leaders of Beijing's support

China remains committed to a "healthy, stable and constructive" relationship with the US amid still "chilly" bilateral ties, Chinese Foreign Minister Qin Gang told visiting American business leaders on Saturday.

Bangkok Post

Michael Hiltzik: Biden says he wants to bring down drug prices. His actions tell a different story

You might get the impression from the Biden administration's insulin price cut and its initiative allowing Medicare to negotiate over other pharmaceuticals that the drug pricing issue is finally being taken seriously in Washington.

Los Angeles Times

Get all your
news in one place.

100’s of premium titles.
One news app.

Kiplinger

Best Defensive Stocks to Buy Now

Investors are concerned about tariffs, inflation, interest rates and economic growth. The best defensive stocks can protect your portfolio against these risks.

The Independent UK

Senators press Moderna CEO on COVID-19 vaccine price hike

Moderna’s CEO is defending a plan to more than quadruple the company’s COVID-19 vaccine price

Fortune

Moderna faces criticism as it prices COVID vaccine at $130 per dose

Pfizer has said it’s considering a similar price for its vaccine.

Axios

Republicans' COVID vaccine tightrope

Experts say there's a fine line between responsibly scrutinizing policy and fueling misinformation.

Get all your
news in one place.

100’s of premium titles.
One news app.

StockNews.com

Adding These 2 Stocks to Your Portfolio Could End up Being a Genius Move

Due to still-high inflation and the Fed’s rate hikes, stock market volatility is anticipated to persist. However, fundamentally sound stocks Pfizer (PFE) and Honda Motor (HMC) could be a solid addition to your portfolio. Let's discuss.

Investors Business Daily

Covid Vaccine Battle Brewing: Moderna's Stephane Bancel Vs. Bernie Sanders

Moderna CEO Stephane Bancel will face off with Sen. Bernie Sanders on Wednesday over the Covid shot. The battle could rock Moderna stock.

StockNews.com

Want to Retire a Millionaire? 2 Stocks to Buy Now

The recent bank failures have increased the likelihood of a recession, with many economists increasing the odds of an economic slump in the next 12 months. Amid this backdrop, investors could buy fundamentally strong stocks, Johnson & Johnson (JNJ) and Pfizer (PFE), which could help retire a millionaire. Read on.

Tribune News Service

Moderna paid the US more than enough for COVID shot partnership, executive says

WASHINGTON — Moderna Inc. plans to tell U.S. lawmakers that it more than adequately compensated the government for its role in a COVID-19 vaccine partnership that brought the drugmaker billions of dollars, a central point in what’s likely to be a heated Capitol Hill hearing this week.

Asharq Al-Awsat

COVID-19 Pill Paxlovid Moves Closer to Full FDA Approval

Pfizer’s COVID-19 pill Paxlovid won another vote of confidence from US health advisers Thursday, clearing the way for its full regulatory approval by the Food and Drug Administration. The medication has been used by millions of Americans since the FDA granted it emergency use authorization in late 2021.

The Independent UK

COVID-19 pill Paxlovid moves closer to full FDA approval

U.S. health advisersare backing the continued use of Pfizer’s COVID-19 pill Paxlovid, saying it remains an important option for adults at high risk of severe illness

StockNews.com

4 Robinhood Stocks to Buy Right Now

Zero-commission trading platform Robinhood is highly attractive to Gen Z and millennial investors. Therefore, stocks traded on the Robinhood platform are considered popular and trending. While all Robinhood stocks are not fundamentally sound, Taiwan Semiconductor Manufacturing (TSM), Pfizer (PFE), General Motors (GM), and Nokia (NOK) hold the potential to deliver…

1 … 24 25 26 27

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Office for National Statistics

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.